Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke.
Chalos V, Venema E, Mulder MJHL, Roozenbeek B, Steyerberg EW, Wermer MJH, Lycklama À Nijeholt GJ, van der Worp HB, Goyal M, Campbell BCV, Muir KW, Guillemin F, Bracard S, White P, Dávalos A, Jovin TG, Hill MD, Mitchell PJ, Demchuk AM, Saver JL, van der Lugt A, Brown S, Dippel DWJ, Lingsma HF; HERMES CollaboratorsMR CLEAN Registry Investigators. Chalos V, et al. Among authors: davalos a. JAMA Neurol. 2023 Jul 31;80(9):940-8. doi: 10.1001/jamaneurol.2023.2392. Online ahead of print. JAMA Neurol. 2023. PMID: 37523199 Free PMC article.
Semi-intensive monitoring in acute stroke and long-term outcome.
Silva Y, Puigdemont M, Castellanos M, Serena J, Suñer RM, García MM, Dávalos A. Silva Y, et al. Among authors: davalos a. Cerebrovasc Dis. 2005;19(1):23-30. doi: 10.1159/000081908. Epub 2004 Nov 3. Cerebrovasc Dis. 2005. PMID: 15528881
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.
Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G; SITS-MOST investigators. Wahlgren N, et al. Among authors: davalos a. Lancet. 2007 Jan 27;369(9558):275-82. doi: 10.1016/S0140-6736(07)60149-4. Lancet. 2007. PMID: 17258667 Clinical Trial.
Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
Castellanos M, Sobrino T, Millán M, García M, Arenillas J, Nombela F, Brea D, Perez de la Ossa N, Serena J, Vivancos J, Castillo J, Dávalos A. Castellanos M, et al. Among authors: davalos a. Stroke. 2007 Jun;38(6):1855-9. doi: 10.1161/STROKEAHA.106.481556. Epub 2007 May 3. Stroke. 2007. PMID: 17478737
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, Grotta JC, Ashwood TJ, Hardemark HG, Svensson HH, Rodichok L, Wasiewski WW, Ahlberg G; CHANT Trial Investigators. Lyden PD, et al. Among authors: davalos a. Stroke. 2007 Aug;38(8):2262-9. doi: 10.1161/STROKEAHA.106.472746. Epub 2007 Jun 14. Stroke. 2007. PMID: 17569876 Clinical Trial.
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hårdemark HG, Rodichok L; SAINT I and II Investigators. Diener HC, et al. Among authors: davalos a. Stroke. 2008 Jun;39(6):1751-8. doi: 10.1161/STROKEAHA.107.503334. Epub 2008 Mar 27. Stroke. 2008. PMID: 18369171 Clinical Trial.
634 results